Target intelligence / Profile preview

Peptidoglycan (bacterial cell wall) and associated biosynthetic proteins

Molecular classification
Other (structural polysaccharide matrix: peptidoglycan), Enzyme (various enzymes involved in biosynthesis: e.g., transpeptidases, transglycosylases), Receptor (for drug targeting, e.g., PBPs as targets of β-lactams)
01

Overview

The bacterial cell wall is a rigid, mesh-like structure composed primarily of peptidoglycan, a network of glycan (sugar) strands cross-linked by peptides, which provides mechanical strength and maintains cell shape while preventing osmotic lysis[1][2][3][4][5]. Peptidoglycan is synthesized by a series of enzymatic steps involving lipid intermediates (like lipid II), glycosyltransferases, and transpeptidases called penicillin-binding proteins (PBPs), which are essential for cell viability and division[1][5]. Associated proteins include a range of biosynthetic enzymes (Mur family, flippases, PBPs), some of which serve as major drug targets for well-established antibiotics (such as β-lactams and glycopeptides), where inhibition leads to cell death by weakening the wall structure[5][3][4]. The cell wall and its associated biosynthesis proteins are unique to bacteria, absent in human cells, making them highly important and specific therapeutic targets in infectious disease[3][4][5]. Note: - The term "Bacterial cell wall and protein" is overly broad and non-standard; for structured information and drug development purposes, split into: “Peptidoglycan” (the cell wall matrix) and precise “cell wall biosynthetic protein name” (e.g., Penicillin-binding protein 2), depending on context[1][5]. - Mechanisms and drugs vary depending on which particular protein or biosynthetic step is referenced (see above for major drugs and mechanisms). - Structural and biosynthetic proteins (such as PBPs, Mur enzymes, flippases) are typical direct molecular targets[1][5].

Other names
bacterial cell wallmureinbacterial peptidoglycanPGNcell wall biosynthetic proteinspenicillin-binding proteins (for subset of proteins)
02

Mechanism of action

Inhibition of peptidoglycan cross-linking (β-lactams bind and inhibit penicillin-binding proteins; glycopeptides bind D-Ala-D-Ala termini of precursors) Blocking cell wall synthesis at early steps (fosfomycin, bacitracin) Disruption of cell wall integrity, leading to cell lysis

03

Biological functions

Maintenance of structural integrityPrevention of osmotic lysisDetermination of cell shapeCell division and elongationAnchorage of surface proteins and factors
04

Disease associations

Infection (as a primary structural feature of pathogenic bacteria and a target for antibiotics)
05

Safety considerations

Allergic reactions (e.g., to β-lactams)Emergence of resistance (e.g., MRSA, VRE—due to altered or replaced target proteins)Off-target effects on native microbiota
06

Interacting drugs

β-lactam antibiotics (penicillins, cephalosporins, carbapenems, monobactams)

4 more in the full profile.

07

Biomarkers

Detection of peptidoglycan fragments (used for diagnosis of bacterial infection)Detection of PBPs or resistance markers (e.g., PBP2a for MRSA detection; not universal)

Beyond the preview

Go deeper on Peptidoglycan (bacterial cell wall) and associated biosynthetic proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidoglycan (bacterial cell wall) and associated biosynthetic proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call